{
    "2021-06-29": [
        [
            {
                "time": "2021-06-29",
                "original_text": "药明康德(02359)因行使股票期权获发行19万股A股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股票期权",
                        "发行A股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-29",
                "original_text": "抗癌龙头突然大跌14%，两大传闻突袭！连续下跌",
                "features": {
                    "keywords": [
                        "抗癌龙头",
                        "大跌",
                        "传闻"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-29",
                "original_text": "恒指收跌0.94%，海底捞强势反弹涨近9%",
                "features": {
                    "keywords": [
                        "恒指",
                        "收跌",
                        "海底捞",
                        "反弹"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-29",
                "original_text": "医药生物行业2021年中期投资策略报告：拥抱新兴产业方向 把握价值低估标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "新兴产业",
                        "价值低估"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-29",
                "original_text": "药明康德附属计划在美国建设含原料药与制剂生产基地",
                "features": {
                    "keywords": [
                        "药明康德",
                        "美国",
                        "生产基地"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-29",
                "original_text": "药明巨诺跌近10% 或遭股东药明康德减持涉资约6.55亿港元 减持股份",
                "features": {
                    "keywords": [
                        "药明巨诺",
                        "减持",
                        "药明康德",
                        "股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-29",
                "original_text": "港股开盘(6.29)︱恒指涨0.08% 药明巨诺-B(02126)低开逾7% 药明康德将出售其2300万股股份 资产异常",
                "features": {
                    "keywords": [
                        "港股",
                        "恒指",
                        "药明巨诺",
                        "低开",
                        "药明康德",
                        "出售股份"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-29",
                "original_text": "CXO赛道未来可期，引药企加速融资扩大产能",
                "features": {
                    "keywords": [
                        "CXO赛道",
                        "融资",
                        "产能"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-29",
                "original_text": "药明康德大幅减持药明巨诺，或是为了旗下细胞基因治疗CDMO板块？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "减持",
                        "药明巨诺",
                        "细胞基因治疗",
                        "CDMO"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}